Authors
Latest:
PCSK9 Inhibitors: Who are the Best Candidates for Therapy?Varying strategies among managed care organizations for PCSK9 inhibitors will shape the care of high-risk cardiovascular patients.
Latest:
Tyrosine-Kinase Inhibitors Well Tolerated, Despite Lack of Tests in Chronic Myeloid Leukemia Patients With Comorbid ConditionsChronic myeloid leukemia patients likely have comorbid conditions at the time of their diagnosis; however, most tyrosine-kinase inhibitor studies exclude patients with these conditions.
Latest:
Emphasize Medication Adherence to PatientsMethods Include Bioingestible Sensors, Motivational Interviewing, Packaging and Reminder Technology, and Synchronization
Latest:
Medicare Part D Insulin Tiering Change: Impact on Health OutcomesThis study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Cost-Effectiveness of Medication Therapy Management in Part D Diabetic EnrolleesPharmacist-delivered medication therapy management is a cost-effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk diabetic Medicare patients.
Latest:
Going Beyond the Prescription in Specialty PharmacyA data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.
Latest:
Telepharmacy and Its Impact on Formulary AdherenceTelepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.
Latest:
New Therapies for Patients With Type 2 DiabetesMany patients with T2D will require insulin therapy; however, these patients are also likely to develop insulin resistance over time.
Latest:
Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient CareThis Continuing Education activity is supported by educational grants from Sanofi-Aventis US Genzyme and Novartis Pharmaceuticals Corporation.
Latest:
An Introduction to Pharmaceutical Industry FellowshipsWith the current increase in pharmacy school enrollment contributing to a more competitive job market, novel and nontraditional career paths may become a more viable option for pharmacy school graduates.
Latest:
Preparing for a Career in Specialty PharmacyThere are a multitude of reasons why pharmacy students choose to pursue a career in specialty pharmacy.
Latest:
Mission Possible: Managing Specialty Pharmacy Costs and UtilizationTo get the right drug in the right amount at the right time to the patient in the most cost-effective manner, the following strategies must be used.
Latest:
Surgery May Be New Option for Those With MigrainesWith over 30 million Americans suffering from migraines, health care professionals are constantly searching for new alternatives to eliminate the disabling pain for patients.
Latest:
Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL ControlEvaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.
Latest:
Watch for Interactions With WarfarinPatients on this therapy should monitor their INR frequently, especially when adding other medications.
Latest:
Clinical Overview: Teprotumumab for Thyroid Eye DiseaseTeprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.
Latest:
Has the US Biosimilar Market Reached a Tipping Point?The launch of a second Remicade biosimilar could open the floodgates to biosimilar competition in the specialty drug market.
Latest:
Electronic Prior Authorization can Increase Dispensing Workflow of Specialty MedicationsElectronic prior authorization may enhance support for a value-based pharmaceutical market.
Latest:
Homeopathy in Pharmacies: The Great DebateTwo speakers faced off during a session at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, Scotland, about whether these products have merit.
Latest:
Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.
